Is Source Natural overvalued or undervalued?
As of August 29, 2025, Source Natural's valuation has improved to attractive, with key metrics indicating it is undervalued compared to peers, featuring a PE Ratio of 28.13 and an EV to EBITDA of 15.68, despite a challenging year with a YTD return of -29.35%.
As of 29 August 2025, Source Natural's valuation grade has moved from fair to attractive, indicating a more favorable assessment of its market position. The company appears to be undervalued based on its current metrics. Key ratios include a PE Ratio of 28.13, an EV to EBITDA of 15.68, and a PEG Ratio of 0.44, suggesting that the stock is priced attractively relative to its growth potential.In comparison to peers, Source Natural's PE Ratio of 28.13 is lower than Sun Pharma's 33.34 and significantly more favorable than Divi's Lab's exorbitant 70.28. Additionally, Source Natural's EV to EBITDA ratio stands at 15.68, which is competitive against Cipla's 16.8 and Dr. Reddy's Labs' 12.24. Despite a challenging year with a YTD return of -29.35%, Source Natural's valuation metrics indicate that it may present a compelling investment opportunity in the current market landscape.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
